Molecular phenotyping of severe asthma

Hot topics
Chairs: Kian Fan Chung (London, United Kingdom), Mona Bafadhel (Oxford, United Kingdom)
Aims: To describe how severe asthma consortia have improved our knowledge of how molecular phenotypes may be linked to clinical features; to define how severe asthma phenotypes vary across the globe; and to outline how integration of the data across consortia will lead to better drugs for selected patients.
SARP: redefining our knowledge of severe asthma
Sally Wenzel (Pittsburgh, United States of America)
WebcastSlide presentation
WebcastSlide presentation
Severe asthma in Asia: insight into phenotypes
Tae-Bum Kim (Seoul, Republic of Korea)
WebcastSlide presentation
WebcastSlide presentation
Data integration: the way to personalised treatment in severe asthma
Peter J. Sterk (Amsterdam, Netherlands)
WebcastSlide presentation
WebcastSlide presentation